Truist Financial’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.7M | Sell |
229,563
-18,116
| -7% | -$1.95M | 0.04% | 347 |
|
|
2025
Q1 | $25M | Buy |
247,679
+31,785
| +15% | +$3.21M | 0.04% | 332 |
|
|
2024
Q4 | $19.3M | Sell |
215,894
-4,801
| -2% | -$429K | 0.03% | 396 |
|
|
2024
Q3 | $18.5M | Buy |
220,695
+6,101
| +3% | +$511K | 0.03% | 416 |
|
|
2024
Q2 | $16.5M | Buy |
214,594
+2,254
| +1% | +$174K | 0.03% | 454 |
|
|
2024
Q1 | $14.5M | Sell |
212,340
-5,103
| -2% | -$350K | 0.02% | 505 |
|
|
2023
Q4 | $12.6M | Sell |
217,443
-46,036
| -17% | -$2.66M | 0.02% | 528 |
|
|
2023
Q3 | $13.9M | Buy |
263,479
+49,323
| +23% | +$2.6M | 0.02% | 480 |
|
|
2023
Q2 | $11.6M | Sell |
214,156
-11,086
| -5% | -$600K | 0.02% | 536 |
|
|
2023
Q1 | $11.3M | Buy |
225,242
+5,142
| +2% | +$257K | 0.02% | 548 |
|
|
2022
Q4 | $10.2M | Sell |
220,100
-26,181
| -11% | -$1.21M | 0.02% | 559 |
|
|
2022
Q3 | $9.54M | Buy |
246,281
+17,912
| +8% | +$694K | 0.02% | 568 |
|
|
2022
Q2 | $8.51M | Sell |
228,369
-16,974
| -7% | -$633K | 0.02% | 623 |
|
|
2022
Q1 | $10.9M | Sell |
245,343
-10,422
| -4% | -$462K | 0.02% | 609 |
|
|
2021
Q4 | $10.9M | Sell |
255,765
-40,126
| -14% | -$1.7M | 0.02% | 613 |
|
|
2021
Q3 | $12.8M | Sell |
295,891
-779,971
| -72% | -$33.8M | 0.02% | 550 |
|
|
2021
Q2 | $46M | Sell |
1,075,862
-386,712
| -26% | -$16.5M | 0.08% | 253 |
|
|
2021
Q1 | $56.5M | Sell |
1,462,574
-240,900
| -14% | -$9.31M | 0.1% | 214 |
|
|
2020
Q4 | $61.2M | Sell |
1,703,474
-128,078
| -7% | -$4.6M | 0.12% | 183 |
|
|
2020
Q3 | $70M | Sell |
1,831,552
-211,807
| -10% | -$8.09M | 0.15% | 149 |
|
|
2020
Q2 | $71.7M | Buy |
2,043,359
+69,660
| +4% | +$2.45M | 0.16% | 146 |
|
|
2020
Q1 | $64.4M | Buy |
1,973,699
+1,333,514
| +208% | +$43.5M | 0.17% | 136 |
|
|
2019
Q4 | $29M | Buy |
640,185
+581,695
| +995% | +$26.3M | 0.06% | 321 |
|
|
2019
Q3 | $2.38M | Buy |
58,490
+5,522
| +10% | +$225K | 0.04% | 324 |
|
|
2019
Q2 | $2.28M | Buy |
52,968
+288
| +0.5% | +$12.4K | 0.04% | 331 |
|
|
2019
Q1 | $2.02M | Buy |
52,680
+8,024
| +18% | +$308K | 0.04% | 348 |
|
|
2018
Q4 | $1.58M | Buy |
44,656
+16,146
| +57% | +$571K | 0.03% | 371 |
|
|
2018
Q3 | $1.1M | Buy |
28,510
+4,062
| +17% | +$156K | 0.02% | 465 |
|
|
2018
Q2 | $800K | Buy |
24,448
+3,846
| +19% | +$126K | 0.02% | 512 |
|
|
2018
Q1 | $563K | Buy |
20,602
+863
| +4% | +$23.6K | 0.01% | 556 |
|
|
2017
Q4 | $490K | Buy |
19,739
+794
| +4% | +$19.7K | 0.01% | 591 |
|
|
2017
Q3 | $552K | Buy |
18,945
+6,019
| +47% | +$175K | 0.01% | 559 |
|
|
2017
Q2 | $359K | Buy |
12,926
+349
| +3% | +$9.69K | 0.01% | 630 |
|
|
2017
Q1 | $313K | Buy |
12,577
+2,817
| +29% | +$70.1K | 0.01% | 680 |
|
|
2016
Q4 | $212K | Buy |
+9,760
| New | +$212K | ﹤0.01% | 779 |
|